Analogues for the treatment or prevention of Flavivirus infections

Details for Australian Patent Application No. 2011232348 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kong, Laval Chan Chun; Giroux, Simon; Reddy, T. Jagadeeswar; Bennani, Youssef L.; Das, Sanjoy Kumar; Maxwell, John; Yannopoulos, Constantin; Liu, Bingcan; Xu, Jingwang; Cottrell, Kevin M.; Morris, Mark A.

Agent Baldwins

Pub. Number AU-A-2011232348

PCT Pub. Number WO2011/119870

Priority 61/316,997 24.03.10 US; 61/360,315 30.06.10 US

Filing date 24 March 2011

Wipo publication date 29 September 2011

International Classifications

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

11 October 2012 PCT application entered the National Phase

  PCT publication WO2011/119870 Priority application(s): WO2011/119870

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011232352-Subterranean and marine-submersible electrical transmission system for oil and gas wells

2011232347-Compositions and methods for the treatment of degenerative diseases